A detailed history of Waterloo Capital, L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Waterloo Capital, L.P. holds 15,068 shares of ABBV stock, worth $2.71 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
15,068
Previous 10,871 38.61%
Holding current value
$2.71 Million
Previous $1.86 Billion 59.59%
% of portfolio
0.32%
Previous 0.22%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $687,636 - $836,588
4,197 Added 38.61%
15,068 $2.98 Billion
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $211,443 - $246,918
-1,366 Reduced 11.16%
10,871 $1.86 Billion
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $15,182 - $17,299
95 Added 0.78%
12,237 $2.23 Billion
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $1.42 Million - $1.6 Million
10,333 Added 571.2%
12,142 $1.88 Billion
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $241,664 - $279,761
1,809 New
1,809 $270 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $365,718 - $421,179
2,529 New
2,529 $403 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Waterloo Capital, L.P. Portfolio

Follow Waterloo Capital, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waterloo Capital, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Waterloo Capital, L.P. with notifications on news.